Lazard Asset Management LLC Acadia Pharmaceuticals Inc Transaction History

Lazard Asset Management LLC

$63.4 Billion
Q2 2025

A detailed history of Lazard Asset Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 35,571 shares of ACAD stock, worth $744,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,571

Previous 187,501 81.03%

Holding current value

$744,856

Previous $3.11 Million 75.37%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$14.1 - $22.95 $2.14 Million - $3.49 Million	-151,930 Reduced 81.03%	35,571 $767,000
Q1 2025 May 15, 2025	BUY	$16.61 - $20.29 $607,477 - $742,066	36,573 Added 24.23%	187,501 $3.11 Million
Q4 2024 Feb 14, 2025	BUY	$14.29 - $18.76 $770,016 - $1.01 Million	53,885 Added 55.53%	150,928 $2.77 Million
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $957,014 - $1.21 Million	63,211 Added 186.84%	97,043 $1.49 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $111,389 - $140,341	7,619 Added 29.07%	33,832 $549,000
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $315,221 - $546,808	17,719 Added 208.61%	26,213 $483,000
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $44,323 - $67,765	2,133 Added 33.53%	8,494 $265,000
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $46,598 - $74,838	2,236 Added 54.21%	6,361 $132,000
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $19,366 - $27,907	1,088 Added 35.82%	4,125 $98,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $49,563 - $63,534	3,037 New	3,037 $57,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $52,051 - $67,398	3,689 New	3,689 $60,000
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $65,228 - $85,662	-3,115 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$16.79 - $27.09 $8,495 - $13,707	506 Added 19.39%	3,115 $72,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $41,170 - $64,624	2,609 New	2,609 $43,000
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $33,927 - $74,566	-1,356 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $49,385 - $77,292	1,356 New	1,356 $55,000
Q2 2020 Aug 13, 2020	SELL	$39.26 - $52.73 $159,395 - $214,083	-4,060 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$31.65 - $46.87 $1.83 Million - $2.71 Million	-57,786 Reduced 93.44%	4,060 $171,000
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $2.21 Million - $3.14 Million	61,031 Added 7488.47%	61,846 $2.65 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $18,109 - $35,868	815 New	815 $29,000

Others Institutions Holding ACAD

# of Institutions

349

Shares Held

163M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Acadia Pharmaceuticals Inc Transaction History